Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer - PubMed
Review
Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer
Ulrika Broomé et al. Semin Liver Dis. 2006 Feb.
Abstract
The prevalence of inflammatory bowel disease (IBD) in patients with PSC differs in various part of the world. Ulcerative colitis (UC) is most common, but 1 to 14% of all primary sclerosing cholangitis (PSC) patients have Crohn disease with colonic involvement. Many PSC patients without clinical symptoms of IBD have colonoscopic and histological findings compatible with IBD, and the subclinical phase may last several years before onset of symptoms of active colitis. The characteristics of UC in patients with PSC are different from those in UC patients without PSC. The colitis is usually substantial, the clinical course of the colitis is quiescent, and rectal sparing is common. Moreover, PSC patients with UC have a higher risk of developing colorectal dysplasia/carcinoma than UC patients without PSC. In patients having an ileal pelvic pouch with ileal anal anastomosis, PSC is a risk factor for development of pouchitis. It is important that all PSC patients with UC are included in colonoscopic surveillance programs.
Similar articles
-
Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Vera A, et al. Transplantation. 2003 Jun 27;75(12):1983-8. doi: 10.1097/01.TP.0000058744.34965.38. Transplantation. 2003. PMID: 12829898
-
Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Gorgun E, et al. Surgery. 2005 Oct;138(4):631-7; discussion 637-9. doi: 10.1016/j.surg.2005.07.014. Surgery. 2005. PMID: 16269291
-
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB, Janse M, Blokzijl H, Weersma RK. de Vries AB, et al. World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956. World J Gastroenterol. 2015. PMID: 25684965 Free PMC article. Review.
-
Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
Fausa O, Schrumpf E, Elgjo K. Fausa O, et al. Semin Liver Dis. 1991 Feb;11(1):31-9. doi: 10.1055/s-2008-1040420. Semin Liver Dis. 1991. PMID: 2047887 Review.
-
Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Brackmann S, et al. Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568. Scand J Gastroenterol. 2009. PMID: 18609187
Cited by
-
Liver disorders in inflammatory bowel disease.
Uko V, Thangada S, Radhakrishnan K. Uko V, et al. Gastroenterol Res Pract. 2012;2012:642923. doi: 10.1155/2012/642923. Epub 2012 Feb 15. Gastroenterol Res Pract. 2012. PMID: 22474447 Free PMC article.
-
A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.
Nannegari V, Roque S, Rubin DT, Quera R. Nannegari V, et al. Gastroenterol Hepatol (N Y). 2014 Oct;10(10):626-30. Gastroenterol Hepatol (N Y). 2014. PMID: 27540334 Free PMC article.
-
Bilateral occlusive retinal vasculitis associated with primary sclerosing cholangitis.
Ansari AS, Bertalot C, Mathews D, Mathews JP. Ansari AS, et al. Saudi J Ophthalmol. 2021 Jul 29;34(4):310-312. doi: 10.4103/1319-4534.322598. eCollection 2020 Oct-Dec. Saudi J Ophthalmol. 2021. PMID: 34527880 Free PMC article.
-
Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
Gidwaney NG, Pawa S, Das KM. Gidwaney NG, et al. World J Gastroenterol. 2017 Apr 14;23(14):2459-2469. doi: 10.3748/wjg.v23.i14.2459. World J Gastroenterol. 2017. PMID: 28465630 Free PMC article. Review.
-
Looking into key bacterial proteins involved in gut dysbiosis.
Zeng XY, Li M. Zeng XY, et al. World J Methodol. 2021 Jul 20;11(4):130-143. doi: 10.5662/wjm.v11.i4.130. eCollection 2021 Jul 20. World J Methodol. 2021. PMID: 34322365 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources